Castle Biosciences, Inc. (CSTL)
USD 19.89
(0.96%)
USD 19.89
(0.96%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.14 USD | 17.05% |
| 2022 | -2.58 USD | -108.06% |
| 2021 | -1.24 USD | -129.63% |
| 2020 | -0.54 USD | -254.29% |
| 2019 | 0.35 USD | 158.33% |
| 2018 | -0.60 USD | 52.38% |
| 2017 | -1.26 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.08 USD | -74.53% |
| 2024 Q2 | 0.32 USD | 447.07% |
| 2024 Q1 | -0.09 USD | 3.35% |
| 2023 Q2 | -0.70 USD | 36.36% |
| 2023 Q1 | -1.10 USD | -41.03% |
| 2023 FY | - USD | 17.05% |
| 2023 Q4 | -0.10 USD | 63.31% |
| 2023 Q3 | -0.26 USD | 62.86% |
| 2022 Q3 | -0.72 USD | -1039.24% |
| 2022 Q2 | -0.06 USD | 93.48% |
| 2022 Q1 | -0.97 USD | -288.0% |
| 2022 FY | - USD | -108.06% |
| 2022 Q4 | -0.78 USD | -8.33% |
| 2021 Q1 | -0.17 USD | 29.17% |
| 2021 Q2 | -0.35 USD | -105.88% |
| 2021 Q3 | -0.47 USD | -34.29% |
| 2021 FY | - USD | -129.63% |
| 2021 Q4 | -0.25 USD | 46.81% |
| 2020 FY | - USD | -254.29% |
| 2020 Q2 | -0.08 USD | -366.67% |
| 2020 Q1 | 0.03 USD | -75.0% |
| 2020 Q4 | -0.24 USD | -4.35% |
| 2020 Q3 | -0.23 USD | -187.5% |
| 2019 Q1 | -0.13 USD | -136.11% |
| 2019 Q4 | 0.12 USD | -72.09% |
| 2019 FY | - USD | 158.33% |
| 2019 Q3 | 0.43 USD | 623.75% |
| 2019 Q2 | -0.08 USD | 36.85% |
| 2018 Q2 | -0.30 USD | 11.76% |
| 2018 Q4 | 0.36 USD | 212.5% |
| 2018 Q1 | -0.34 USD | 0.0% |
| 2018 FY | - USD | 52.38% |
| 2018 Q3 | -0.32 USD | -6.67% |
| 2017 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aspira Women's Health Inc. | -1.81 USD | -18.232% |
| bioAffinity Technologies, Inc. | -0.91 USD | -135.165% |
| Intelligent Bio Solutions Inc. | -6.38 USD | 66.458% |
| Standard BioTools Inc. | -0.94 USD | -127.66% |
| Inotiv, Inc. | -4.10 USD | 47.805% |
| Prenetics Global Limited | -5.58 USD | 61.649% |
| Neuronetics, Inc. | -1.05 USD | -103.81% |
| Star Equity Holdings, Inc. | 7.42 USD | 128.841% |
| Psychemedics Corporation | -0.72 USD | -197.222% |
| RadNet, Inc. | 0.05 USD | 4567.641% |
| Exact Sciences Corporation | -1.13 USD | -89.381% |
| IDEXX Laboratories, Inc. | 10.17 USD | 121.042% |
| iSpecimen Inc. | -1.23 USD | -73.984% |
| OpGen, Inc. | -41.47 USD | 94.84% |
| Exagen Inc. | -1.34 USD | -59.701% |
| Bionano Genomics, Inc. | -6.81 USD | 68.576% |
| CareDx, Inc | -3.54 USD | 39.548% |
| Check-Cap Ltd. | -3.00 USD | 28.667% |
| Twist Bioscience Corporation | -3.60 USD | 40.556% |
| Guardant Health, Inc. | -4.28 USD | 50.0% |
| Biodesix, Inc. | -0.64 USD | -234.375% |
| BioNexus Gene Lab Corp. | -0.17 USD | -1158.824% |
| Precipio, Inc. | -4.51 USD | 52.55% |
| Natera, Inc. | -3.78 USD | 43.386% |
| Fulgent Genetics, Inc. | -5.63 USD | 61.989% |
| Sera Prognostics, Inc. | -1.16 USD | -84.483% |
| 23andMe Holding Co. | -1.40 USD | -52.857% |
| OPKO Health, Inc. | -0.25 USD | -756.0% |
| Personalis, Inc. | -2.25 USD | 4.889% |
| Aclaris Therapeutics, Inc. | -1.27 USD | -68.504% |
| Applied DNA Sciences, Inc. | -15.21 USD | 85.93% |
| T2 Biosystems, Inc. | -19.19 USD | 88.848% |
| Neogen Corporation | -0.04 USD | -4819.54% |
| Myriad Genetics, Inc. | -1.39 USD | -53.957% |
| ICON Public Limited Company | 7.46 USD | 128.686% |
| NeoGenomics, Inc. | -0.70 USD | -205.714% |
| Star Equity Holdings, Inc. | 7.42 USD | 128.841% |
| MDxHealth SA | -1.66 USD | -28.916% |
| Prenetics Global Limited | -5.58 USD | 61.649% |
| Illumina, Inc. | -7.35 USD | 70.884% |
| DarioHealth Corp. | -1.93 USD | -10.881% |
| ENDRA Life Sciences Inc. | -1.11 USD | -92.793% |
| Medpace Holdings, Inc. | 9.20 USD | 123.261% |
| Mainz Biomed B.V. | -1.62 USD | -32.099% |
| Trinity Biotech plc | -3.14 USD | 31.847% |
| Sotera Health Company | 0.18 USD | 1288.889% |
| bioAffinity Technologies, Inc. | -0.91 USD | -135.165% |